AZEVAN PHARMACEUTICALS INC — Form D
AZEVAN PHARMACEUTICALS INC of BETHLEHEM, PA, a company, filed a Form D exempt-offering notice with the SEC on 2013-10-18. The offering totals $6.5M, of which $2.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-10-18
- Form: D
- Accession: 0001334514-13-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $6.5M
- Amount sold: $2.2M
- Remaining: $4.3M
- Minimum investment: $10K
- Investors: 4
- Date of first sale: 2013-10-04
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-204832
Issuer
- Name: AZEVAN PHARMACEUTICALS INC
- CIK: 0001334514
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 116 RESEARCH DRIVE, BETHLEHEM, PA, 18015
- Phone: 610-419-1057
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Morton G Hyman | Director | New York, NY |
| Paul J Maddon | Director | Scarsdale, NY |
| Carter G Meyer | Director | Dallas, TX |
| Mike G Pavia | Director | Durham, NC |
| Neal G Simon | Director | Bethlehem, PA |
| Geoffrey G Smith | Director | New York, NY |
| Neal G Simon | Executive Officer | Bethlehem, PA |
More